These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17112585)

  • 1. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
    Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
    Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
    Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
    Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
    Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.
    Arvat E; Di Vito L; Lanfranco F; Broglio F; Giordano R; Benso A; Muccioli GP; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1999 Feb; 22(2):91-7. PubMed ID: 10195374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.
    Frieboes RM; Antonijevic IA; Held K; Murck H; Pollmächer T; Uhr M; Steiger A
    Psychoneuroendocrinology; 2004 Aug; 29(7):851-60. PubMed ID: 15177700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Gauna C; Filtri L; Arvat E; van der Lely AJ; Deghenghi R; Ghigo E
    J Endocrinol Invest; 2003 Mar; 26(3):192-6. PubMed ID: 12809167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
    Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
    Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
    Arvat E; Maccagno B; Ramunni J; Gianotti L; Di Vito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Lys(3)-GHRP-6 antagonizes the effect of unacylated but not of acylated ghrelin on the growth of HECa10 murine endothelial cells.
    Polowinczak-Przybylek J; Siejka A; Melen-Mucha G
    Peptides; 2012 Dec; 38(2):248-54. PubMed ID: 23044212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.
    Delhanty PJ; van Koetsveld PM; Gauna C; van de Zande B; Vitale G; Hofland LJ; van der Lely AJ
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E302-9. PubMed ID: 17405826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa.
    Fassino S; Daga GA; Mondelli V; Pierò A; Broglio F; Picu A; Giordano R; Baldi M; Arvat E; Ghigo E; Gianotti L
    Psychoneuroendocrinology; 2005 Jul; 30(6):534-40. PubMed ID: 15808922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
    Maccario M; Veldhuis JD; Broglio F; Vito LD; Arvat E; Deghenghi R; Ghigo E
    Eur J Endocrinol; 2002 Mar; 146(3):310-8. PubMed ID: 11888836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
    de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
    Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
    Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
    Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans.
    Schüssler P; Uhr M; Ising M; Weikel JC; Schmid DA; Held K; Mathias S; Steiger A
    Psychoneuroendocrinology; 2006 Sep; 31(8):915-23. PubMed ID: 16814473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.